← Back to home

PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI

Clinical trials for PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI explained in plain language.

Never miss a new study

Get alerted when new PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI trials appear

Sign up with your email to follow new studies for PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Yale tests 'Magic Mushroom' microdoses on brain and mood

Knowledge-focused Not yet recruiting

This small pilot study aims to understand how taking very small, non-psychedelic doses of psilocybin (from 'magic mushrooms') over 30 days affects mood, thinking skills, and brain activity. Researchers will compare 20 healthy adults who have never used psychedelics, giving some t…

Matched conditions: PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI

Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused

Last updated Apr 04, 2026 06:20 UTC

PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI

Get alerted when new PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI trials appear

Yale tests 'Magic Mushroom' microdoses on brain and mood